June 12, 2019
Several scientific studies have shown that intestinal flora can affect well-being. Now Lund company Gutfeeling Labs is launching an analysis service aimed at private individuals. It provides individualized information on both bacterial composition and on functions of the intestinal flora that could potentially promote well-being. In addition to the analysis results, information is also provided on how to positively impact the intestinal flora. Gutfeeling Labs is a company in SmiLe Incubator at Medicon Village in Lund, Sweden.
Gutfeeling Labs was founded by Walter Fischer and Hans Fischer, associate professors in neuroscience and immunology, respectively, at Lund University.
“We want to offer a financially reasonable intestinal flora analysis and provide information on diet and dietary supplements that can be useful for the public. We all have our individual intestinal flora and learning about it provides a starting point for possible change – a personal balancing of the intestinal flora,” says Hans Fischer.
The unique analysis service that they have developed, which is based on the latest research in the field, is soon to be launched, beginning in Sweden. Their concept is based on a combination of gene technology for identification of bacteria and the use of a database with information on the metabolism of the intestinal bacteria. The unique feature of this method is that it enables identification of the proportion of the total intestinal flora that can produce, for example, butyric acid, a substance that has been shown to have a stabilizing effect on the intestinal barrier and has potential anti-inflammatory properties. The proportion of the intestinal flora capable of breaking down dietary fiber can also be measured. This information is of interest because research has shown that increased breakdown of certain dietary fibers can decrease hunger and sugar cravings.
Hans Fischer has studied intestinal flora for about ten years and has shown that one particular type of colitis is linked to low levels of the Akkermansia bacterium that lives in the intestinal mucosa.
Walter Fischer, a neurosurgeon, became interested in intestinal flora in conjunction with research that he conducted on immunotherapy in patients with glioblastoma (brain cell cancer) that was published in the prestigious periodical Nature Communications in 2018. His study showed that brain tumors shrunk in some patients, but not in others.
“Knowledge about the status of the intestinal flora provides a foundation to relate to, and based on information about diet and dietary supplements, an opportunity to promote growth of bacteria that produce health-promoting substances,” says Hans Fischer.
READ MORE, a longer version is found at www.Smileincubator.life under "press".
For more information, please contact: info [at] gutfeelinglabs.se; Hans Fischer +46 (0)708 541 868, Walter Fischer +46 (0)709 58 6001